Highly Biocompatible Nanoparticles of Au@Fluorescent Polymers as Novel Contrast Agent for In Vivo Bimodality NIR Fluorescence/CT Imaging

<div>Cell toxicity assay. Measurement of HUVECs and astrocyte cells viability by MTT assay (a); ROS measurement (b): fluorescence images of DCFH in HUVECs control (A), HUVECs incubated with H<sub>2</sub>O<sub>2</sub> as positive control (B), and treatment with Au@FPs nanoparticles (C). Western blotting with anti-LC3 antibody of HUVECs treatment with Au@FPs nanoparticles and <i>β</i>-actin served as the loading control (c).</div>

Contrast Media & Molecular Imaging

fig3

Figure 3

Figure 3: Highly Biocompatible Nanoparticles of Au@Fluorescent Polymers as Novel Contrast Agent for In Vivo Bimodality NIR Fluorescence/CT Imaging 